530 related articles for article (PubMed ID: 37891636)
1. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies.
Hassani B; Attar Z; Firouzabadi N
Cancer Cell Int; 2023 Oct; 23(1):254. PubMed ID: 37891636
[TBL] [Abstract][Full Text] [Related]
2. Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors.
Azushima K; Morisawa N; Tamura K; Nishiyama A
Curr Hypertens Rep; 2020 Feb; 22(3):22. PubMed ID: 32114685
[TBL] [Abstract][Full Text] [Related]
3. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
4. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Differentially Articulated Axes of the Century-Old Renin-Angiotensin-Aldosterone System: Potential Therapeutic Implications.
Balakumar P; Handa S; Alqahtani A; Alqahtani T; Khan NA; LakshmiRaj RS; Thangathirupathi A; Sundram K; Shenoy V
Cardiovasc Toxicol; 2022 Mar; 22(3):246-253. PubMed ID: 35143015
[TBL] [Abstract][Full Text] [Related]
7. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
Li XY; Peng Y; Bu XW; Yao J; Yao L
Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
[TBL] [Abstract][Full Text] [Related]
8. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
Nishiyama A; Kim-Mitsuyama S
J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
[TBL] [Abstract][Full Text] [Related]
9. 2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus.
Simões E Silva AC; Lanza K; Palmeira VA; Costa LB; Flynn JT
Pediatr Nephrol; 2021 Jun; 36(6):1407-1426. PubMed ID: 32995920
[TBL] [Abstract][Full Text] [Related]
10. Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension.
Moon JY
Electrolyte Blood Press; 2013 Dec; 11(2):41-5. PubMed ID: 24627703
[TBL] [Abstract][Full Text] [Related]
11. Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities.
Gupta D; Kumar A; Mandloi A; Shenoy V
Pharmacol Res; 2021 Dec; 174():105924. PubMed ID: 34607005
[TBL] [Abstract][Full Text] [Related]
12. A New Perspective on the Renin-Angiotensin System.
Martyniak A; Tomasik PJ
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611307
[TBL] [Abstract][Full Text] [Related]
13. Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review.
Holappa M; Vapaatalo H; Vaajanen A
Ann Med; 2020 Aug; 52(5):191-206. PubMed ID: 32308046
[TBL] [Abstract][Full Text] [Related]
14. Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1-7)/MAS receptor axes in human mesangial cells.
Stoll D; Yokota R; Sanches Aragão D; Casarini DE
Physiol Rep; 2019 Jun; 7(11):e14105. PubMed ID: 31165585
[TBL] [Abstract][Full Text] [Related]
15. Potential of Renin-Angiotensin-Aldosterone System Modulations in Diabetic Kidney Disease: Old Players to New Hope!
Malek V; Suryavanshi SV; Sharma N; Kulkarni YA; Mulay SR; Gaikwad AB
Rev Physiol Biochem Pharmacol; 2021; 179():31-71. PubMed ID: 32979084
[TBL] [Abstract][Full Text] [Related]
16. New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
Gromotowicz-Poplawska A; Szoka P; Kolodziejczyk P; Kramkowski K; Wojewodzka-Zelezniakowicz M; Chabielska E
Exp Biol Med (Maywood); 2016 Nov; 241(17):1888-1899. PubMed ID: 27439538
[TBL] [Abstract][Full Text] [Related]
17. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
Liu J; Chen Q; Liu S; Yang X; Zhang Y; Huang F
Life Sci; 2018 Sep; 208():139-148. PubMed ID: 29990483
[TBL] [Abstract][Full Text] [Related]
18. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.
Atlas SA
J Manag Care Pharm; 2007 Oct; 13(8 Suppl B):9-20. PubMed ID: 17970613
[TBL] [Abstract][Full Text] [Related]
20. The RAAS Goodfellas in Cardiovascular System.
Caputo I; Bertoldi G; Driussi G; Cacciapuoti M; Calò LA
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
